Resources search

Disability measurement in household surveys : A guidebook for designing household survey questionnaires (English). LSMS guidebook.

TIBERTO, Marco
COSTA, Valentina
January 2020

Expand view

This Guidebook supports the implementation of the Washington Group Short Set (WG-SS) – a set of questions designed to identify (in a census or survey format) people with a disability – in multi-topic household surveys, towards improving the collection of disaggregated disability data. The first section presents an overview of the disability definitions in the sociopsychological literature, exploring how disability is defined and who is considered disabled. The second section looks at three different methods for capturing disability in multi-topic household surveys: the Washington Group (WG) question sets, the World Health Organization (WHO) survey instruments for disabilities, and the Demographic and Health Surveys (DHS) module on disabilities. The third section presents the six core WG-SS functional domains, ‘seeing’, ‘hearing’, ‘walking’, ‘cognition’, ‘selfcare’, and ‘communication’, that are intended for the general population five years of age and above. Finally, the Guidebook offers a series of recommendations for ensuring the improvement of disability data collection in multi-topic household survey.

The little data book on gender 2013

CUI, Liu
et al
2013

Expand view

This guide is "a quick reference for users interested in gender statistics. The book presents gender-disaggregated data for more than 200 economies in an easy country-by-country reference on demography, education, health, labor force, political participation and the Millennium Development Goals. The book’s summary pages cover regional and income group aggregates"

Finance for all? policies and pitfalls in expanding access

DEMIRGUC-KUNT, Asli
BECK, Thorsten
HONOHAN, Patrick
2007

Expand view

This report is a broad-ranging review of research work focusing on access to finance. It presents indicators to measure financial access, analyzes its determinants, and evaluates the impact of access on growth, equity, and poverty reduction. The report also discusses the role of government in advancing financial inclusion
A World Bank Policy Research Report

Disease control priorities in developing countries. 2nd edition. Chapter 2. Intervention cost-effectiveness: overview of main messages.

LAXMINARAYAN, Ramanan
et al
2006

Expand view

Drawing from the collective knowledge and analytical work of the many experts who have contributed to this volume, this chapter provides a broader perspective on the relative efficiency and effect on health of a number of interventions than is possible in a single, condition-specific chapter. The objective is to provide information on the cost-effectiveness estimates for 319 interventions covering nearly every disease condition considered in the volume, and the resulting avertable burden of disease. This chapter provides broad conclusions on the economic efficiency of using these interventions to improve health.

 

Disease control priorities in developing countries. 2nd edition. Chapter 15. Cost-effectiveness analysis for priority setting.

MUSGROVE, Phillip
FOX-RUSHBY, Julia
2006

Expand view

What cost-effectiveness analysis (CEA) does and does not provide, how it is related to the concept of burden of disease, and how it can be used, along with other criteria, in setting priorities is discussed. The several meanings of the term CEA and the way that interventions are classified and evaluated are described. Estimating the effectiveness of an intervention requires specifying the units which in turn requires choices of several parameter values, including, in the analyses reported here, the discount rate applied to future years; the disability weights that describe the severity of diseases and conditions, corresponding to the health losses that they cause; and the life expectancy at different ages. Costs of interventions to include in the analysis, and conversion of costs to equivalents in U.S. dollars for international comparisons are described. Variations of results and uncertainty of estimates are discussed. Two ways are suggested to consider costs and outcomes at the population level, allowing for large differences among countries in the size of population; the incidence or prevalence of a disease, condition, or risk factor; and the amount spent or available to spend on an intervention

E-bulletin